PO.TB01.01 · 肿瘤生物学
对失调肿瘤血管系统的热调控
Thermal regulation of dysbiotic tumor vasculature
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
抗生素的使用多年来大幅增加。虽然口服抗生素可治疗感染,但它们也会剧烈改变肠道菌群,扰乱对维持多种稳态过程至关重要的共生细菌。我们最近已发表和未发表的工作表明,胃肠道菌群失调会引起远端肿瘤基质的剧烈变化,导致多种实体瘤的癌症进展加速。我们发现菌群失调可显著抑制肿瘤内皮细胞上的黏附分子。相反,局部热疗越来越被认为可引发多种细胞反应,然而热疗对ABX诱导菌群失调期间肿瘤血管系统的影响尚不清楚。我们发现热疗(41.5℃或43℃处理60分钟,与37℃相比)对多种黏附分子有不同程度的影响。尤其是43℃处理1小时的热疗暴露能够克服菌群失调期间肿瘤血管系统上发现的黏附分子抑制。使用脾细胞和T细胞的功能研究表明,血管黏附分子的诱导性增加导致白细胞栓系增加。尽管仍需进一步研究,但这些结果表明热疗发挥免疫调节作用,并能够克服菌群失调诱导的表型。由于目前的全身性抗癌治疗常受其毒性限制,局部热疗未来可能成为一种可行的替代方案。
查看英文原文 English abstract
Antibiotic use has substantially increased over the years. Although oral antibiotics treat infections, they also drastically change the gut microbiota, disturbing commensal bacteria that are essential for maintaining a number of homeostatic processes. Our recent published and unpublished work have shown that GI-tract dysbiosis causes drastic changes to the stroma of distal tumors, resulting in accelerated cancer progression of various solid tumors. We discovered that dysbiosis induces a significant suppression of adhesion molecules on tumor endothelial cells. Conversely, localized hyperthermia has been increasingly recognized to elicit various cellular responses, yet the effects of hyperthermia on the tumor vasculature during ABX-induced dysbiosis are unknown. We found that hyperthermia (60 min of either 41.5 °C or 43 °C, as compared to 37 °C) influenced various adhesion molecules to different degrees. Especially hyperthermic exposure of 43 °C for 1 hr was able to overcome the adhesion-molecule suppression found on the tumor vasculature during dysbiosis. Functional studies with splenocytes and T cells demonstrated that the induced increase in vasculature adhesion molecules caused increased tethering of leukocytes. Although further studies are warranted, these results demonstrate that hyperthermia exerts immune modulating effects and is capable of overcoming the dysbiosis-induced phenotype. Since current systemic anti-cancer treatments are often limited by their toxicities, localized hyperthermia may become a viable alternative in the future.
利益披露 Disclosure
A. A. Brint, None..
H. Kristian, None..
S. Jenkins, None..
R. Griffin, None..
R. P. Dings, None.